Glial Cell Dysfunction in C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

M Ghasemi, K Keyhanian, C Douthwright - Cells, 2021 - mdpi.com
Since the discovery of the chromosome 9 open reading frame 72 (C9orf72) repeat
expansion mutation in 2011 as the most common genetic abnormality in amyotrophic lateral …

GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performance

K Katisko, A Cajanus, N Huber… - Journal of Neurology …, 2021 - jnnp.bmj.com
Background Frontotemporal lobar degeneration (FTLD) and primary psychiatric disorders
(PPD) are characterised by overlapping clinical features but different aetiologies. Here, we …

Peripheral inflammation in behavioural variant frontotemporal dementia: associations with central degeneration and clinical measures

M Chu, L Wen, D Jiang, L Liu, H Nan, A Yue… - Journal of …, 2023 - Springer
Background Neuroinflammation plays a significant role in the progression of frontotemporal
dementia (FTD). However, the association between peripheral inflammatory factors and …

C9orf72 dipeptides activate the NLRP3 inflammasome

J Rivers-Auty, C Hoyle, A Pointer… - Brain …, 2024 - academic.oup.com
Frontotemporal dementia and amyotrophic lateral sclerosis are neurodegenerative diseases
with considerable clinical, genetic and pathological overlap. The most common cause of …

Inflammatory plasma profile in genetic symptomatic and presymptomatic Frontotemporal Dementia− A GENFI study

C Fenoglio, M Serpente, M Arcaro, T Carandini… - Brain, Behavior, and …, 2024 - Elsevier
Background Inflammation has been proposed as a crucial player in neurodegeneration,
including Frontotemporal Dementia (FTD). A few studies on sporadic FTD lead to …

Plasma inflammation for predicting phenotypic conversion and clinical progression of autosomal dominant frontotemporal lobar degeneration

BM Asken, PA Ljubenkov, AM Staffaroni… - Journal of Neurology …, 2023 - jnnp.bmj.com
Background Measuring systemic inflammatory markers may improve clinical prognosis and
help identify targetable pathways for treatment in patients with autosomal dominant forms of …

Brainstem atrophy is linked to extrapyramidal symptoms in frontotemporal dementia

S Heikkinen, A Cajanus, K Katisko, P Hartikainen… - Journal of …, 2022 - Springer
Extrapyramidal (EP) symptoms are a known feature in a subpopulation of patients with
behavioral variant frontotemporal dementia (bvFTD). Concomitant EP symptoms with FTD …

Gamma‐induction in frontotemporal dementia (GIFTeD) randomized placebo‐controlled trial: Rationale, noninvasive brain stimulation protocol, and study design

M Assogna, G Sprugnoli, D Press… - … Research & Clinical …, 2021 - Wiley Online Library
Introduction Frontotemporal dementia (FTD) is a neurodegenerative disorder for which there
is no effective pharmacological treatment. Recently, interneuron activity responsible for fast …

Interrogating the plasma proteome of repetitive head impact exposure and chronic traumatic encephalopathy

R Saloner, KB Casaletto, S Rayaprolu, P Chakrabarty… - bioRxiv, 2024 - biorxiv.org
Background: Exposure to repetitive head impacts (RHI) is associated with increased risk for
chronic traumatic encephalopathy (CTE), a neurodegenerative tauopathy, and other …

[PDF][PDF] Allostatic Interoception in Frontotemporal Dementia: A Scoping Review Protocol

F Carneiro, J Hazelton, C Campos, A Ibáñez… - 2024 - researchgate.net
Frontotemporal dementia (FTD) encompasses a spectrum of disorders characterized by
distinct behavioral, cognitive, and motor symptoms. Deficits in interoception and allostasis …